Derek Small
Net worth: 964 650 $ as of 31/05/2026
Net worth: 964 650 $ as of 31/05/2026
Derek A. Small is the founder of Luson Bioventures LLC, founded in 2007, serving as Managing Director.
Mr. Small was the founder of Assembly Biosciences, Inc., founded in 2014, serving as Director from 2019 to 2020.
Mr. Small was the founder of Assembly Pharmaceuticals, Inc., founded in 2012, serving as Executive Chairman & Chief Executive Officer.
Mr. Small was the founder of Gate Neurosciences, Inc., founded in 2018, serving as Executive Chairman.
Mr. Small is the founder of Monument Biosciences, Inc., founded in 2022, serving as Chief Executive Officer.
Mr. Small is also the founder of Syndeio Biosciences..
Mr. Small is currently a Director at Anagin, Inc. Mr. Small is currently a Board Member at BioCrossroads since 2017.
Former positions include Advisor & CEO at EndGenitor Technologies, Inc. from 2007 to 2009; President, Chief Executive Officer & Director at Naurex, Inc. from 2012 to 2014; President, Chief Executive Officer & Director at BlinkBio, Inc. from 2008 to 2011 and from 2009 to 2012; Director-Strategic Alliances at Simdesk Technologies, Inc.; Independent Director at Innoviva, Inc. from 2024 to 2026; Head-Business Development & Regulatory Affairs at Semafore Pharmaceuticals, Inc.; and Advisor at Kinagen, Inc. Education includes undergraduate studies at Franklin College of Indiana, Inc. and Harlaxton College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INNOVIVA, INC. 0.06% | 04/05/2026 | 45,035 ( 0.06% ) | 964 650 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Luson Bioventures LLC
Luson Bioventures LLC Investment ManagersFinance Operates as venture capital firm | Founder | 01/01/2007 |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical, medical device, diagnostics, ag-biotech, health information technology and platforms sectors. It provides financing for seed and early stage capital requirements. | Director/Board Member | 01/07/2017 |
Anagin, Inc.
Anagin, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for post-traumatic stress disorder | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 12/05/2026 |
| ASSEMBLY BIOSCIENCES, INC. | Chief Executive Officer | 06/08/2019 |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules | Chief Executive Officer | 01/04/2012 |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules | Chief Executive Officer | 30/06/2011 |
EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc. BiotechnologyHealth Technology Commercialized adult stem cell products | Chief Executive Officer | 21/03/2009 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 15 |
|---|---|
Simdesk Technologies, Inc.
Simdesk Technologies, Inc. Packaged SoftwareTechnology Services Provides web based software solutions and services | Technology Services |
EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc. BiotechnologyHealth Technology Commercialized adult stem cell products | Health Technology |
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and discovers drugs for multiple disorders including cancer | Retail Trade |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Health Technology |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules | Health Technology |
Innoviva, Inc.
Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical, medical device, diagnostics, ag-biotech, health information technology and platforms sectors. It provides financing for seed and early stage capital requirements. | Finance |
Harlaxton College
Harlaxton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Luson Bioventures LLC
Luson Bioventures LLC Investment ManagersFinance Operates as venture capital firm | Finance |
Kinagen, Inc.
Kinagen, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services | Health Technology |
Assembly Pharmaceuticals, Inc.
Assembly Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies biopharmaceutical products | Health Technology |
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Anagin, Inc.
Anagin, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for post-traumatic stress disorder | Health Technology |
Gate Neurosciences, Inc.
Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Franklin College of Indiana, Inc.
Franklin College of Indiana, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions